ICIS News – Activist premise on Dow spin false (January 27, 2014)news2021-07-01T19:40:22+00:00January 27th, 2014|Our Publications|
Pharma and Biotech Financial Trends: Every Which Way (Young & Partners article written for the Pharma Exec Dec 2013 Issue)news2021-07-01T19:40:28+00:00December 1st, 2013|Our Publications|
Activist Investors Target Chemicals (Young & Partners article in ICIS Oct. 1 – 13, 2013)news2021-07-01T19:40:33+00:00October 1st, 2013|Our Publications|
Chemical M&A Rebound Continues (Young & Partners article in ICIS Sept 30 – Oct 6, 2013)news2021-07-01T19:40:39+00:00September 30th, 2013|Our Publications|
Chemical M&A Market Revives (Young & Partners article in ICIS July 15 – 28, 2013)news2021-07-01T19:40:45+00:00July 15th, 2013|Our Publications|
Sunny Outlook for Chemical Financing (Young & Partners article in ICIS Feb. 25 – March 3, 2013)news2021-07-01T19:40:51+00:00February 25th, 2013|Our Publications|
Banker – M&A down in 2012, But Improving (Chemical Week Feb. 18, 2013 Issue)news2021-07-01T19:40:56+00:00February 18th, 2013|Our Publications|
Chemical M&A Market Down But Not Out (Young & Partners article in ICIS Feb 11-17, 2013)news2021-07-01T19:41:02+00:00February 11th, 2013|Our Publications|
Breaking Waves – Turbulent Times for the Biopharma Business (Young & Partners Article in Pharma Exec Nov 2012 Issue)news2012-11-01T09:00:19+00:00November 1st, 2012|Our Publications|
Banker – Big uptick in chemical debt financing (Chemical Week October 2, 2012)news2012-10-02T09:00:47+00:00October 2nd, 2012|Our Publications|
